Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd (AGARWALEYE) last traded at ₹501, a market capitalisation of ₹15,888 crore, on a P/E of 108. Over the past 52 weeks the stock has ranged between ₹401 and ₹568. Dr. Agarwals Health Care Ltd last reported results for the quarter ended Jun 2026, with sales of ₹614 crore and net profit of ₹55 crore. Figures are as of 25 Aug 2026 and are not real time.
Dr. Agarwals Health Care Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Dr. Agarwals Health Care Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹614 cr, up 26.1% from ₹487 cr a year earlier. Net profit was ₹55 cr, up 44.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 417 | 431 | 460 | 487 | 499 | 530 | 564 | 614 |
| Expenses | 310 | 316 | 329 | 360 | 363 | 386 | 403 | 444 |
| Operating profit | 107 | 115 | 131 | 128 | 136 | 144 | 161 | 170 |
| OPM % | 26% | 27% | 28% | 26% | 27% | 27% | 29% | 28% |
| Other income | 12 | 13 | 13 | 13 | 8 | 11 | 14 | 6 |
| Interest | 28 | 28 | 25 | 25 | 23 | 21 | 22 | 23 |
| Depreciation | 57 | 58 | 60 | 63 | 68 | 69 | 77 | 78 |
| Profit before tax | 33 | 41 | 59 | 54 | 54 | 65 | 77 | 75 |
| Tax % | 36% | 31% | 27% | 29% | 32% | 33% | 35% | 27% |
| Net profit | 21 | 28 | 43 | 38 | 36 | 44 | 50 | 55 |
| EPS (₹) | — | 0.72 | 1.03 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Dr. Agarwals Health Care Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 471 | 696 | 1,018 | 1,332 | 1,711 | 2,080 | 2,207 |
| Operating profit | 85 | 186 | 275 | 367 | 463 | 570 | 612 |
| OPM % | 18% | 27% | 27% | 28% | 27% | 27% | 28% |
| Net profit | -59 | 43 | 103 | 95 | 110 | 168 | 185 |
| EPS (₹) | — | — | — | — | 2.64 | 4.20 | 4.69 |
TTM is the trailing twelve months to the most recent quarter.
Dr. Agarwals Health Care Ltd growth and returns
- 10 Years
- %
- 5 Years
- 35%
- 3 Years
- 27%
- TTM
- 23%
- 10 Years
- %
- 5 Years
- 34%
- 3 Years
- 13%
- TTM
- 43%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 8%
- 10 Years
- %
- 5 Years
- 8%
- 3 Years
- 6%
- Last Year
- 7%
Dr. Agarwals Health Care Ltd shareholding pattern
Promoters held 32.34% at Jun 2026, broadly unchanged since Jun 2025. FIIs 57.97% and DIIs 7.72%.
| % held | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 32.45% | 32.43% | 32.43% | 32.39% | 32.35% | 32.34% |
| FIIs | 60.62% | 59.26% | 58.13% | 58.06% | 57.94% | 57.97% |
| DIIs | 5.21% | 6.44% | 7.92% | 7.78% | 7.83% | 7.72% |
| Public | 1.74% | 1.87% | 1.52% | 1.78% | 1.87% | 1.97% |
| No. of shareholders | 68,696 | 63,021 | 48,168 | 46,554 | 43,538 | 42,492 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Dr. Agarwals Health Care Ltd corporate filings
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Dr. Agarwal’s Health Care Limited has reported a fresh pledge creation of 75.38 lakh…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DB International Trust (Singapore) LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Dr. Agarwal’s Health Care Limited (the 'Target Company') has seen a significant change in…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Claymore Investments (Mauritius) Pte LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Dr. Agarwals Health Care Limited has witnessed a significant stake sale by a major…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hyperion Investments Pte LtdInsider Trading / SASThigh impact
Cruxal's analysis: Dr. Agarwal’s Health Care Limited faces a significant stake sale by a major institutional…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual FundInsider Trading / SASTmedium impact
Cruxal's analysis: Invesco Mutual Fund has disclosed an acquisition of 69.38 lakh equity shares of Dr…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Dr. Agarwal’s Health Care Limited has reported a partial release of encumbrance over 3.17…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual FundInsider Trading / SASTmedium impact
Cruxal's analysis: ICICI Prudential Mutual Fund has disclosed the acquisition of 1 crore 69 lakh 99 thousand…
Read the full analysis - Transcript of the discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, at the analyst call held on August 04, ....Company Updatehigh impact
Cruxal's analysis: Dr. Agarwal's Healthcare Limited delivered robust Q1 FY27 results, with revenue from…
Read the full analysis - Link for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30, ....Company Updatelow impact
Cruxal's analysis: Dr. Agarwal's Health Care Limited has formally filed the audio recording of its analyst…
Read the full analysis - Dr. Agarwal''s Health Care Limited - Monitoring Agency Report for the quarter ended June 30, 2026, is submitted.Company Updatelow impact
Cruxal's analysis: Dr. Agarwals Health Care Limited has submitted its Monitoring Agency Report for the…
Read the full analysis - Presentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, is attached.Company Updatehigh impact
Cruxal's analysis: Dr. Agarwal's Health Care Limited announced strong consolidated financial results for…
Read the full analysis - Consolidated and Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2026 is submitted.Resulthigh impact
Cruxal's analysis: Dr. Agarwal's Health Care Limited has announced robust consolidated financial results for…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Dr. Agarwals Health Care Ltd
Cruxal reads every Dr. Agarwals Health Care Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.